Search research articles
Contact Us
Filters
Showing results (711-720 of 752) with videos related to
Page
of 76
Sort By:
Transplantation and Cellular Therapy
|
February 15, 2025
Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL Patients
Chihiro Yamamoto, Seina Honda, Ryutaro Tominaga, et al.
Biochimica Et Biophysica Acta
|
December 23, 2006
Bio-photosensor: Cyanobacterial photosystem I coupled with transistor via molecular wire
Nao Terasaki, Noritaka Yamamoto, Kaoru Tamada, et al.
Annals of Hematology
|
June 24, 2020
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma
Takashi Nagayama, Masahiro Ashizawa, Takashi Ikeda, et al.
Annals of Hematology
|
June 27, 2019
Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy
Kento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
September 17, 2020
Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft-vs-host disease-a retrospective study
Takashi Nagayama, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Leukemia & Lymphoma
|
April 6, 2019
Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma
Kento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pathology, Research and Practice
|
September 26, 2024
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressions
Yumiko Toda, Ken Ohmine, Naoki Sano, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2019
Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease
Kaoru Morita, Masahiro Ashizawa, Yumiko Toda, et al.
Hematological Oncology
|
September 8, 2025
Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma
Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, et al.
Internal Medicine (Tokyo, Japan)
|
April 4, 2022
Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome
Shoko Ito, Shin-Ichiro Fujiwara, Tomoaki Yoshizawa, et al.
Page
of 76
Search research articles
Search
Showing results (711-720 of 752) with videos related to
Sort By:
Page
of 76
Transplantation and Cellular Therapy
|
February 15, 2025
Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL Patients
Chihiro Yamamoto, Seina Honda, Ryutaro Tominaga, et al.
Biochimica Et Biophysica Acta
|
December 23, 2006
Bio-photosensor: Cyanobacterial photosystem I coupled with transistor via molecular wire
Nao Terasaki, Noritaka Yamamoto, Kaoru Tamada, et al.
Annals of Hematology
|
June 24, 2020
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma
Takashi Nagayama, Masahiro Ashizawa, Takashi Ikeda, et al.
Annals of Hematology
|
June 27, 2019
Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy
Kento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
September 17, 2020
Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft-vs-host disease-a retrospective study
Takashi Nagayama, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Leukemia & Lymphoma
|
April 6, 2019
Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma
Kento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pathology, Research and Practice
|
September 26, 2024
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressions
Yumiko Toda, Ken Ohmine, Naoki Sano, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2019
Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease
Kaoru Morita, Masahiro Ashizawa, Yumiko Toda, et al.
Hematological Oncology
|
September 8, 2025
Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma
Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, et al.
Internal Medicine (Tokyo, Japan)
|
April 4, 2022
Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome
Shoko Ito, Shin-Ichiro Fujiwara, Tomoaki Yoshizawa, et al.
Page
of 76